While after traumatic brain injury (TBI) the endogenous IGF-1 level has been shown to increase, in multiple sclerosis (MS), which is one of the most deeply studied demyelinating diseases, a local deficiency of this growth factor has been observed, often within the areas of demyelination. The gene discussed is IGF1; the disease is demyelinating disease.